TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Abroad (travel likely)RecruitingPHASE2
Conditions
Primary Immune Deficiency Disorders · Metabolic Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Johns Hopkins All Children's Hospital, St. Petersburg, Florida, United States
Contact: Principal Investigator (Deepak Chellapandian, MD)
Study leads
Deepak Chellapandian, MD
Principal Investigator
Johns Hopkins All Children's Hospital